Bloomage BioTechnology Corporation Limited (688363.SS)
CNY 54.85
(-1.7%)
CNY 54.85
(-1.7%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 713.42 Million | 635.18 Million | 1.27 Billion | 705.12 Million | 364.89 Million | 442.29 Million |
| Net Income | 592.55 Million | 961.38 Million | 775.55 Million | 645.01 Million | 584.61 Million | 423.85 Million |
| Depreciation & Amortization | 292.39 Million | 213.61 Million | 154.33 Million | 70.18 Million | 60.39 Million | 46.88 Million |
| Deferred income taxes | -34.95 Million | -61.78 Million | -150.16 Million | -50.18 Million | -22.67 Million | -6.51 Million |
| Stock-based compensation | 42.5 Million | 90.97 Million | 97.88 Million | - | - | 22.13 Million |
| Change in working capital | -253.16 Million | -670.87 Million | 208.4 Million | -25.22 Million | -292.33 Million | -26.54 Million |
| Other non-cash items | 954.56 Million | 88.99 Million | 190.04 Million | 15.15 Million | 12.21 Million | -1.89 Million |
| Investing Cash Flow | -620.66 Million | -836.22 Million | -989.86 Million | -1.33 Billion | -1.24 Billion | -34.52 Million |
| Investments in PPE | -1.03 Billion | -696.41 Million | -784.2 Million | -762.77 Million | -450.22 Million | -168.42 Million |
| Acquisitions | 5.99 Million | -155.03 Million | -138.08 Million | 61.35 Thousand | 802.99 Million | -431.65 Million |
| Investment purchases | -1.38 Billion | -123.3 Million | -1.96 Million | -10.94 Million | -803 Million | - |
| Sales/Maturities of investments | 1.79 Billion | 32.58 Million | 32.52 Million | 38.28 Million | 2.77 Million | 29.17 Million |
| Other Investing Activities | 579.87 Million | 105.94 Million | -98.13 Million | -595.93 Million | -799.99 Million | 536.38 Million |
| Financing Cash Flow | -533.56 Million | -170.15 Million | -71.35 Million | -159.93 Million | 2.22 Billion | 85.21 Million |
| Debt repayment | -106.36 Million | -36.71 Million | -16.18 Million | -23.83 Million | -40 Million | -40 Million |
| Dividends payments | -293.82 Million | -235.73 Million | -196.8 Million | -177.6 Million | - | -1 Billion |
| Common Stock Repurchased | -105.89 Million | - | - | -17.66 Million | - | - |
| Common Stock Issuance | - | - | - | -6.17 Million | - | - |
| Other Financing Activities | 40.05 Million | 109.42 Million | 145.84 Million | 65.33 Million | 2.26 Billion | 1.09 Billion |
| Accounts receivables | 54.48 Million | -98.42 Million | -36.27 Million | -64.93 Million | -181.36 Million | 18.29 Million |
| Accounts payables | -321.53 Million | -72.84 Million | 613.38 Million | 268.41 Million | 53.39 Million | -18.75 Million |
| Inventory | 13.88 Million | -437.81 Million | -218.53 Million | -178.51 Million | -141.7 Million | -19.56 Million |
| Other working capital | 42.5 Million | -61.78 Million | -150.16 Million | -50.18 Million | -22.67 Million | -6.97 Million |
| Cash at beginning of period | 1.6 Billion | 1.58 Billion | 1.38 Billion | 2.18 Billion | 840.91 Million | 331.87 Million |
| Cash at end of period | 1.16 Billion | 1.24 Billion | 1.58 Billion | 1.38 Billion | 2.18 Billion | 840.91 Million |
| Capital Expenditure | -1.03 Billion | -696.41 Million | -784.2 Million | -762.77 Million | -450.22 Million | -168.42 Million |
| Effect of forex changes on cash | 10.56 Million | 29.55 Million | -19.85 Million | -12.35 Million | 6.16 Million | 16.04 Million |
| Net cash flow / Change in cash | -437.41 Million | -341.63 Million | 194.98 Million | -798.47 Million | 1.34 Billion | 509.04 Million |
| Free Cash Flow | -316.9 Million | -61.22 Million | 491.85 Million | -57.65 Million | -85.33 Million | 273.87 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 20.25 Million | 98.39 Million | 243.36 Million | 592.55 Million | 78.15 Million | 89.79 Million |
| Depreciation & Amortization | - | 81.74 Million | 81.74 Million | 292.39 Million | 75.01 Million | -127.49 Million |
| Deferred income taxes | - | - | - | -34.95 Million | - | 34.01 Million |
| Stock-based compensation | - | 5.87 Million | - | 42.5 Million | 42.5 Million | -25.63 Million |
| Change in working capital | - | -249.85 Million | - | -253.16 Million | 110.86 Million | 112.51 Million |
| Other non-cash items | -11.28 Million | 238.25 Million | -201.37 Million | 954.56 Million | 475.89 Million | -34.73 Million |
| Investing Cash Flow | -105.51 Million | -170.51 Million | -62.08 Million | -620.66 Million | -242.2 Million | -194.86 Million |
| Investments in PPE | -126.92 Million | -230.73 Million | -228.36 Million | -1.03 Billion | -272.76 Million | -192.05 Million |
| Acquisitions | 210.06 Thousand | - | - | 5.99 Million | -54.26 Thousand | 100.00 |
| Investment purchases | -108.15 Thousand | -211.97 Million | -128.7 Million | -1.38 Billion | -1.3 Billion | -4.29 Million |
| Sales/Maturities of investments | 1.3 Million | 567.18 Million | 7.13 Million | 1.79 Billion | 1.83 Billion | 1.48 Million |
| Other Investing Activities | 20.21 Million | -294.98 Million | 294.98 Million | 579.87 Million | -497.52 Million | -1999.26 |
| Financing Cash Flow | -98.23 Million | -32.23 Million | -220.2 Million | -533.56 Million | -112.46 Million | -28.49 Million |
| Debt repayment | -91.27 Million | -791 Thousand | -104.68 Million | -106.36 Million | -564.42 Thousand | -530.28 Thousand |
| Dividends payments | -182.05 Million | - | -1.3 Million | -293.82 Million | -300.34 Million | -7.45 Million |
| Common Stock Repurchased | 114.52 Million | -114.52 Million | - | -105.89 Million | -108.24 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -7.45 Million | 112.28 Million | -115.51 Million | 40.05 Million | 364.59 Million | -20.5 Million |
| Accounts receivables | - | -174.23 Million | - | 54.48 Million | 54.48 Million | 106.04 Million |
| Accounts payables | - | - | - | -321.53 Million | - | 25.63 Million |
| Inventory | - | -81.49 Million | - | 13.88 Million | 13.88 Million | 6.47 Million |
| Other working capital | - | 5.87 Million | - | 42.5 Million | 42.5 Million | -25.63 Million |
| Cash at beginning of period | 623.56 Million | 836.12 Million | 1.16 Billion | 1.6 Billion | 1.12 Billion | 875.01 Million |
| Cash at end of period | 434.8 Million | 657.89 Million | 836.12 Million | 1.16 Billion | 1.16 Billion | 692.95 Million |
| Capital Expenditure | -126.92 Million | -230.73 Million | -228.36 Million | -1.03 Billion | -272.76 Million | -192.05 Million |
| Effect of forex changes on cash | 5.56 Million | -553.5 Thousand | -1.52 Million | 10.56 Million | 3.36 Million | -7.16 Million |
| Net cash flow / Change in cash | -188.75 Million | -178.23 Million | -332.59 Million | -437.41 Million | 41.62 Million | -182.05 Million |
| Free Cash Flow | -117.95 Million | 24.17 Million | -186.37 Million | -316.9 Million | 206.27 Million | -143.59 Million |
SICALLOG
TAST
VCON
PANXF
AFT
IOS